Basilea Pharmaceutica Ltd. Logo
 

Dr. Gerrit Hauck, Chief Technology Officer

 
 
Dr. Gerrit Hauck, Chief Technology Officer  
Dr. Gerrit Hauck, German citizen, serves as Chief Technology Officer since May 2018. He joined Basilea from Sanofi, where he was Cluster Head Synthetic Molecules since January 2015. In this role he was overseeing most of the company’s technical development programs for synthetic molecules from pre-clinical candidates to launch. Since January 2012 he was a member of Sanofi’s Research Stage Gate Committee, which is responsible for the transition of candidate molecules from research into development. He has over 24 years of experience in various technical operations and management functions at Sanofi and its predecessor companies, which involved formulation development, plant management and global CMC leadership. Dr. Hauck graduated as a pharmacist from the University of Heidelberg, Germany and holds a PhD from Saarland University, Germany.
 
Info